Molecular Partners AG

MOLN

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001745114

SEC filings (opens in a new tab)

No open-market purchases or sales by Molecular Partners AG insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Molecular Partners AG changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of MOLN: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	7	7	0
Shares	929.5K	960.4K	+30.9K (+3.3%)
Value	$5.73M	$3.91M	−$1.82M (−31.8%)

New holders (1)

Institutions that held Molecular Partners AG at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to MOLN in Q3 2023
Institution	Shares	Value	% of portfolio
Qube Research & Technologies Ltd	16	$64	0.00%

Sold out (1)

Institutions that held Molecular Partners AG at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of MOLN in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Jane Street Group, LLC	16,816	$101.8K